sponsorship of Medscape, LLC and JNCCN - The Journal of the National Comprehensive Cancer Network . Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians. Medscape, LLC designates this Journal-based CME activity for
Search Results
Risk Assessment and Prophylaxis for VTE in Cancer Patients
Alok A. Khorana
Short Screening Tools for Cancer-Related Distress: A Review and Diagnostic Validity Meta-Analysis
Alex J. Mitchell
distress, which had previously received little attention compared with depression. 1 Distress is a very common complication of cancer at any stage and often occurs when multiple needs are unmet. 2 , 3 The presence of distress is also linked with reduced
Association Between Frailty and Time Alive and At Home After Cancer Surgery Among Older Adults: A Population-Based Analysis
Julie Hallet, Bourke Tillman, Jesse Zuckerman, Matthew P. Guttman, Tyler Chesney, Alyson L. Mahar, Wing C. Chan, Natalie Coburn, Barbara Haas, and members of the Recovery after Surgical Therapy for Older adults Research–Cancer (RESTORE-Cancer) Group
Background Older adults have the highest incidence of cancer and represent the fastest growing group of individuals requiring cancer surgery. 1 – 3 Shared decision-making with older adults, in particular regarding surgery, has inherent
Heparin-Induced Thrombocytopenia in Cancer
Benjamin J. Miriovsky and Thomas L. Ortel
is the basis for treatment with direct thrombin inhibitors. 7 The heparin-PF4 antibodies are detectable in the laboratory using immunologic or functional assays, and are often used to support the clinical suspicion of HIT. Patients with cancer
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
Bhumsuk Keam, Jeong-Hoon Lee, Seock-Ah Im, and Jung-Hwan Yoon
Korea, which is regarded as an endemic area of HBV infection, a nationwide survey revealed an HBsAg prevalence of 5.1% in men and 4.1% in women. 4 Reactivation of HBV has been well documented in infected patients receiving chemotherapy for cancer
Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation
Sanjay Chawla, Cristina Gutierrez, Prabalini Rajendram, Kenneth Seier, Kay See Tan, Kara Stoudt, Marian Von-Maszewski, Jorge L. Morales-Estrella, Natalie T. Kostelecky, and Louis P. Voigt
Background Cancer remains a leading cause of mortality, even surpassing heart disease in some high-income areas and countries. 1 – 4 Nonetheless, advances in earlier detection, therapeutics, and management have led to an overall accelerated
Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery
Alyssa A. Schatz, Keysha Brooks-Coley, Elizabeth Harrington, Mary Stober Murray, and Robert W. Carlson
Background The healthcare and cancer care systems are no exception to the racial disparities that pervade United States society. Cancer care systems are deeply impacted by interpersonal, organizational, and structural and systemic racism, and
Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?
Natalie Moryl, Tito R. Mendoza, Susan D. Horn, Jelyn C. Eustaquio, Charles S. Cleeland, and Charles Inturrisi
Background Among the most difficult challenges presented by the prescription opioid abuse crisis are its implications for the treatment of cancer pain. Access of patients with cancer pain to opioid analgesia has decreased significantly
Adult Cancer Pain
Robert Swarm, Amy Pickar Abernethy, Doralina L. Anghelescu, Costantino Benedetti, Craig D. Blinderman, Barry Boston, Charles Cleeland, Nessa Coyle, Oscar A. deLeon-Casasola, June G. Eilers, Betty Ferrell, Nora A. Janjan, Sloan Beth Karver, Michael H. Levy, Maureen Lynch, Natalie Moryl, Barbara A. Murphy, Suzanne A. Nesbit, Linda Oakes, Eugenie A. Obbens, Judith A. Paice, Michael W. Rabow, Karen L. Syrjala, Susan Urba, and Sharon M. Weinstein
Overview Pain, defined as “a sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage,” 1 is one of the most common symptoms associated with cancer. Cancer pain or cancer
Modification and Implementation of NCCN Guidelines™ on Hepatobiliary Cancers in the Middle East and North Africa Region
Muhammed Aasim Yusuf, Vinay Kumar Kapoor, Refaat Refaat Kamel, Ather Kazmi, Najam Uddin, Nehal Masood, and Abdulmajeed Al-Abdulkareem
T he 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Hepatobiliary Cancers (to view the most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org ) addresses 4 main tumor groups
